Search Results 741-750 of 13609 for beyondfor
Evaluating the efficacy of ION-682884 after administration for 65 weeks, as compared to the historical control of the placebo cohort (inotersen) in the NEURO- ...
About this study. The purpose of the study is to test different doses of X4P-001 given alone and in combination with axitinib in patients diagnosed with ...
About this study. We hypothesize that clinical studies to investigate the role of individual proteins in kidney stone pathogenesis have likely been ...
LB-100 is a small molecule that in laboratory and animal studies has shown activity when used by itself or together with drugs approved to treat some types of ...
AJRR-C investigators develop natural language processing tools for automated extraction of surgical data from electronic health records. Related publication: Fu ...
Cohort C: Triple-negative breast cancer (TNBC);; Cohort D: Platinum-resistant/refractory epithelial ovarian, primary peritoneal, or fallopian tube cancer ( ...
Analyzing the genetic makeup of breast cancer cells to understand how DNA changes affect response to cancer treatments and personalize treatment options.
Veliparib With Carboplatin and Paclitaxel and as Continuation Maintenance Therapy in Subjects With Newly Diagnosed Stage III or IV, High-grade Serous, ...
Learn more about this type of cancer that affects your throat (pharynx), voice box (larynx) or tonsils.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.